← Back
A

$ Value

$0

Shares

23,710

Price

$0

Filed

Aug 11

Insider

Name

WELDON WILLIAM C

Title

CIK

0001189019

Roles

Director

Transaction Details

Transaction Date

2025-08-07

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,710

Footnotes

Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis. | Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis. | The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.

Filing Info

Accession No.

0001628280-25-039737

Form Type

4

Issuer CIK

0001464521

WELDON WILLIAM C's History

Date Ticker Type Value
2025-08-11 HTFL C
2025-08-11 HTFL C
2025-08-11 HTFL C
2025-08-11 HTFL C
2025-08-07 HTFL A $0

Other Insiders at HTFL (90d)

Insider Bought Sold Last
BARABE TIMOTHY C 2026-03-11
HealthCor Partners Management LP 2026-03-24
Lightcap Jeffrey C 2026-03-24
Rogers Campbell
Chief Medical Officer
$4.8M 2026-04-01
Bain Capital Life Sciences Investors, LLC $56.1M 2026-02-04
Cullivan Julie A $447K 2026-03-05
Farquhar John C.M.
Chief Executive Officer
$1.8M 2026-04-10
Jones Marie L.
Chief Accounting Officer, VP
2026-02-06
Verghese Vikram
Chief Financial Officer
2026-02-06